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Abstract: 
Background - Dysregulation of voltage-gated cardiac Na+ channels (NaV1.5) by inherited 
mutations, disease-linked remodeling, and drugs causes arrhythmias.  The molecular 
mechanisms whereby the NaV1.5 voltage-sensing domains (VSDs) are perturbed to 
pathologically or therapeutically modulate Na+ current (INa) have not been specified. Our aim 
was to correlate INa kinetics with conformational changes within the four (DI-DIV) VSDs to 
define molecular mechanisms of NaV1.5 modulation. 
Method and Results - Four NaV1.5 constructs were created to track the voltage-dependent 
kinetics of conformational changes within each VSD, using voltage-clamp fluorometry (VCF).  
Each VSD displayed unique kinetics, consistent with distinct roles in determining INa. In 
particular, DIII-VSD deactivation kinetics were modulated by depolarizing pulses with durations 
in the intermediate time domain that modulates late INa. We then used the DII-VSD construct to 
probe the molecular pathology of two Brugada Syndrome (BrS) mutations (A735V and G752R).  
A735V shifted DII-VSD voltage-dependence to depolarized potentials, while G752R 
significantly slowed DII-VSD kinetics.  Both mutations slowed INa activation, even though DII-
VSD activation occurred at higher potentials (A735V) or at later times (G752R) than ionic 
current activation, indicating that the DII-VSD allosterically regulates the rate of INa activation 
and myocyte excitability. 
Conclusions - Our results reveal novel mechanisms whereby the NaV1.5 VSDs regulate its 
activation and inactivation. The ability to distinguish distinct molecular mechanisms of proximal 
BrS mutations demonstrates the potential of these methods to reveal how inherited mutations, 
post-translational modifications and anti-arrhythmic drugs alter NaV1.5 at the molecular level.
Key words: sodium channels, Brugada syndrome, ion channel 
DOI: 10.1161/CIRCEP.115.003155
3
Introduction
Atrial and ventricular action potentials (AP) are initiated by a large membrane-depolarizing Na+
flux through the cardiac voltage-gated Na+ channel, NaV1.5.  In large animals and humans, 
persistent NaV1.5 current is also a significant regulator of AP duration. Because of its central role 
in determining the AP, molecular-level interactions that perturb NaV1.5 channel function have a 
significant impact on the ability of the myocardium to initiate and sustain arrhythmias.  
Mutations to NaV1.5 are known to cause Long QT Syndrome Type 3 (LQT3), Brugada 
Syndrome (BrS), Sick Sinus Syndrome, Atrial Fibrillation and Familial Heart Block 1, 2.  Further, 
class I small molecule anti-arrhythmics target the NaV1.5 pore with the aim of diminishing Na+
current to prevent arrhythmia3.  To date, characterization of NaV1.5 mutation pathology and drug 
interactions has primarily relied on measuring the ionic current response to elaborately designed 
voltage-pulse protocols.  Here, we develop novel NaV1.5 constructs to augment these protocols 
by monitoring changes in conformation with fluorescence labeling, at the same time that we 
observe the ionic current, with voltage-clamp fluorometry (VCF).  By applying VCF to observe 
channels that carry inherited mutations, we expect to improve phenotypic precision by 
characterizing the molecular pathology of the disease.  
The NaVĮ-subunit, encoded by SCN5A, is composed of four homologous domains 
(DI-DIV), each with six transmembrane-spanning segments (S1-S6).  Within DI-DIV, S1-S4 
form the voltage-sensing domains (VSD), which respond to changes in membrane potential (Vm)
to cause NaV1.5 gating. The NaV1.5 pore is formed by the S5-S6 segments.  A hydrophobic 
triplet (IFM) located in the intracellular DIII/DIV linker is required for inactivation4, and its 
action is modulated by the C-terminus5.
 Previously, VCF was used to relate skeletal muscle Na+ channel, NaV1.4, VSD
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conformations to channel activation and inactivation6-10 and to probe the domain-specific 
interactions of toxins11-13 and local anesthetics14, 15.
 In this study, we present four novel constructs that report on the distinctive VSD 
conformations of NaV1.5 for the purpose of assessing molecular mechanisms of NaV1.5-linked 
pathologies and therapies.  To demonstrate the potential of the method, we probe the molecular 
phenotype of two proximal BrS1 mutations, A735V and G752R, which are both located on the 
DII-VSD.  The ECG phenotypes of patients with each mutation differ.  Patients with A735V 
present with S-T segment elevation in leads V1-V316, while those with G752R show S-T
segment elevation17 in addition to a prominent J wave in leads II, III, and aVF18. We 
hypothesized that in addition to ECG differences, there may also exist fundamentally different 
molecular pathologies, despite the proximity of the mutations.
Materials and Methods
Voltage clamp fluorometry
cRNAs for human NaVĮ- DQGȕ1-subunits were injected into Xenopus laevis oocytes for cut-
open oocyte recordings19, 20 at 19°C. The internal solution was (mmol/L): 105 NMG-Mes, 10 Na-
Mes, 20 HEPES, and 2 EGTA, pH 7.4, and the external solution was composed of (mM): 25 
NMG-Mes, 90 Na-Mes, 20 HEPES, and 2 Ca-Mes2, pH 7.4. For gating currents, 10 ȝM TTX 
was used, and Na-Mes was replaced by NMG-Mes. For fluorescence recordings, oocytes were 
labeled with 10 μmol/L methanethiosulfonate-carboxytetramethylrhodamine (MTS-TAMRA).  
Data was collected on a custom rig (see Supplemental Methods).  Animal procedures were 
performed according to institutional guidelines. 
Data analysis 
For photobleaching correction, baseline fluorescence recorded over time without voltage pulsing  
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was subtracted from traces recorded during the application of the voltage protocol. Fluorescence 
magnitude is expressed as 'F/F0, 'F is the signal amplitude change and F0 is baseline 
fluorescence.
Steady-state voltage-dependence was quantified by Boltzmann-function fitting: 
y=1/(1+exp[(V-V1/2)/k)]. t10-90% for current activation is the duration between 10 and 90% of the
ionic current peak. For fluorescence signals, t10-90%C was calculated from the time constants of 
single exponential fits (W).
Statistical comparisons were done using paired or independent-sample t-tests or one-way 
ANOVA with post-hoc tests for pairwise comparison. p<0.05 was considered significant. The ± 
symbols in the text and error bars in the figures represent the 95% confidence interval (95CI) 
with number of trials (n) in parentheses.  
Results
Our first aim was to create four NaV1.5 constructs to track conformational changes within each 
of the  NaV1.5 channel VSDs. Initial attempts to record fluorescence signals were unsuccessful 
due to insufficient expression of human NaV1.5, which is significantly reduced compared to rat 
NaV1.4, the isoform used to acquire most existing Na+ channel VCF data.  Examination of 
differences between the two channels revealed that NaV1.5 contains an ubiquitination motif that 
enhances the channel recycling rate and reduces the number of channels in the membrane21; this 
motif is not found in NaV1.4.  Ablation of the ubiquitination site by the Y1977A mutation and 
co-LQMHFWLRQZLWKȕ1-subunit RNA resulted in sufficient NaV1.5 expression for the detection of 
useful fluorescence signals.  We also introduced C373Y, increasing tetrodotoxin22 (TTX) 
sensitivity and allowing ionic current blockade for the measurement of gating currents.  This 
mutation also removes an externally accessible cysteine, preventing non-specific labeling. 
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 Two protocols were performed to compare our new construct to wild type. We first 
quantified the conductance-voltage (G-V) relationship, found by measuring peak current after a 
series of depolarizing pulses and dividing by driving force.  The second protocol measured the 
voltage-dependence of steady state inactivation (SSI); peak current was measured during a short 
test pulse to -20 mV that followed 200-ms inactivation-inducing pulses to varying potentials.  
The voltage-dependence of the G-V and SSI curves were not substantially affected by these 
mutations (Fig. 1, p=0.951 and 0.069, respectively). For fluorescence tracking, cysteine 
mutations (specified below) in the individual domains were introduced in this Y1977A-C373Y 
mutant, which we named WT-LFS (Large Fluorescence Signal). The mutants produced for VSD-
tracking in this background will be accordingly referred to as DI-LFS, DII-LFS, DIII-LFS, and 
DIV-LFS. Cysteines were introduced at several positions within each VSD, but most of these did 
not produce useful signals. We were fortunate to find a single useful site for each domain.
To track the conformation of the DI-VSD, we tested ten positions from L212 to T220 and 
R222.  V215C (DI-LFS) was the only mutant to express well and produce a usable fluorescence 
signal (Fig 2). The NaV1.5 VSDs play an essential role in determining gating, and we expected 
the TAMRA-MTS labeling in conjunction with the introduced cysteine to affect gating to some 
extent.  We observed a negative shift ('V1/2=-16.8 mV) in the G-V and a slight positive shift 
('V1/2=+8 mV) in the SSI curves compared to the background WT-LFS construct, implying that 
the labeled V215C channel opens at more negative potentials and inactivates at more positive 
potentials than WT-LFS.  Comparing labeled and unlabeled DI-LFS showed that the G-V shift is 
a consequence of adding the TAMRA-MTS label (Figure S1).  We also used gating currents to 
assess whether charge movement across the transmembrane electric field was affected by 
labeling (Fig. S2).  If the probe significantly affected charge transfer, we would expect to 
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observe a change in the voltage-dependence of the gating current integral, the gating charge.  For 
the four constructs, the charge-voltage (Q-V) relationship was shifted over a range of 5 to 11 mV 
in comparison to WT-LFS (Fig. S1 and Table 1), suggesting that charge displacement was 
modestly affected by cysteine-conjugated fluorophore replacement of the WT residue.
 Simultaneously recording changes in fluorescence magnitude during these protocols 
allowed us to correlate DI-VSD conformations to channel gating.  We refer to the fluorescence 
that was recorded during the G-V protocol as the fluorescence-voltage relationship (F-V curve) 
and the fluorescence from the SSI protocols as the SSI F-V curve. The F-V curves reflect the 
voltage-dependence of the conformations in the DI-VSD that are reported by TAMRA.  For the 
DI-VSD, the midpoint of the F-V curve was 27.2 mV negative of the G-V curve, indicating that 
DI-VSD movement occurs at much more negative potentials than pore opening.  On the contrary, 
the SSI and SSI F-V curves had very similar midpoints, showing that inactivation and DI-VSD 
movement occur in the same voltage range.  However, in contrast to DIV (see below), the DI-
VSD SSI F-V and SSI slopes differed substantially (k=-15.4(5) vs -6.4 mV(8), respectively,
p<0.001), suggesting that the two events are not tightly coupled. 
The fluorescence kinetics recorded during the F-V curve reflect the voltage-dependent 
rates of VSD activation and deactivation. Since current and VSD activation kinetics are
described by different functions, we measured the time between 10% and 90 % of the peak 
current and calculated t10-90%C for fluorescence (see Methods). DI-VSD rise-time was slower
(t10-90%C=0.82±0.23 ms at +30 mV) than ionic current activation (t10-90%=0.24±0.04 ms), but the 
events overlapped due to the sigmoidal delay in ionic current activation (Fig. S3).  At elevated 
potentials (> +20 mV) a slow component in the DI-VSD fluorescence signal became apparent 
with an opposite sign relative to the original deflection. While significant numbers of channels 
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will not make this slow transition to a new state during a single AP, channels may accumulate in 
this state at rapid heart rates.
 Since fast inactivation is known to hinder the recovery of the gating charges upon 
repolarization (immobilization), we performed experiments to measure the deactivation rate of 
the DI-VSD after depolarizing pulses of varying length, which inactivated the channels to 
different extents. The deactivation kinetics measured at -120 mV did not change as a function of 
pulse duration (t10-90%C=0.99±0.22 ms after a 2 ms pulse and 0.99±0.13 ms after a 200 ms pulse, 
(4), p=0.948). This result suggests that DI-VSD deactivation is not influenced by NaV1.5 open-
state inactivation, which had not occurred during the 2 ms pulse and is nearly complete after 200 
ms.
We tracked the DII-VSD with S805C (DII-LFS), which yielded large and robust signals.  
The voltage-dependent steady-state parameters (G-V and SSI curves) were minimally affected in 
comparison to WT-LFS; there was no shift in the G-V curve and a +7.4 mV shift in the SSI 
curve (Fig. 3).  Measurement of the F-V revealed that it was 12.5 mV negative of the G-V curve,
showing that the DII-VSD starts to move prior to activation; however, it reaches saturation at 
higher potentials than the conductance due to its shallower slope, which indicates that the two 
events are not tightly coupled.  Comparing the SSI and SSI-FV curves shows that inactivation 
occurs at more negative potentials than DII-VSD activation (V½=-79.2 and -52.2 mV,
respectively), and that the inactivation slope is much steeper than DII-VSD activation (k=-6.5 
and -17.5 mV, respectively, (7,6), p<0.001).  Thus, at holding potentials which completely 
abolish the conductance by inactivation (V>-50 mV), the DII-VSD is still far from having 
completed its motion, likely precluding it from participating in closed-state inactivation. The DI-
VSD and DII-VSDs activate at similar rates (t10-90%C=0.98±0.19 ms at +30 mV, (5) p=0.332), 
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and, when superimposed on the ionic current, DII-VSD activation precedes ionic current 
activation (Fig. S3). As for DI, the DII-VSD deactivation kinetics are not substantially affected
by the length of the depolarizing pulse (t10-90%C=0.86±0.29 ms after 2 ms and 0.99±0.13 ms after 
200 ms, (4), p=0.171).
Conformations in the DIII-VSD were tracked with M1296C (DIII-LFS), which was the 
only construct to produce a signal out of I1299C, K1300C, and S1301C.   The DIII construct had 
G-V and SSI curves nearly identical to those of DII, but relative to the DII-VSD, the F-V and 
SSI F-V curves were dramatically shifted by -54.6 and -70.3 mV, respectively (Fig. 4).  
Comparison to the G-V and SSI curves shows that DIII-VSD activation precedes pore opening 
by a large voltage margin during activation, and similarly, during inactivation, most of the VSD 
movement is completed before any noticeable drop in the conductance due to inactivation. 
Activation kinetics of the DIII-VSD were similar to those of DI and DII (t10-90%C = 0.81±0.25 ms 
at +30 mV, (5), p=0.332), although deactivation was >10x slower. Furthermore, in contrast to DI 
and DII, the deactivation kinetics of the DIII-VSD were significantly slowed when the duration 
of depolarizing pulse was increased (t10-90%C = 12.85±2.37 ms after a 2 ms pulse and 18.58±1.58 
after 200 ms, (6), p=0.009). The markedly slowed deactivation of the DIII-VSD following long 
depolarizations indicates that its return could be inhibited by entry of the channel into the deeper 
inactivated states that occur after longer depolarizations, which stabilize it in the activated 
conformation. 
 Finally, to track the DIV-VSD, we introduced S1618C (DIV-LFS) and L1621C (no 
signal). The unlabeled DIV-LFS construct displays a non-saturating SSI curve that is corrected 
by fluorophore conjugation.  Recording of the unlabeled construct with a reducing agent 
confirmed that this phenomenon was due to disulphide bond formation in the absence of the 
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fluorophore (Figure S1).   Both the G-V and SSI curves of the DIV-VSD construct were shifted
relative to WT-LFS by +5.3 and +12.4 mV, respectively (Fig. 5). Comparison of the 
fluorescence and ionic current shows that the midpoint of the F-V curve was 32.2 mV more 
negative than that of the G-V, while the SSI and SSI F-V curves overlapped, further supporting 
strong correlation between DIV-VSD activation and closed-state inactivation that is primarily 
measured by the SSI curve. In addition, slowing of fast inactivation caused by the introduction of 
the cysteine mutation is also readily apparent in the ionic current recordings.  In comparison to 
the other three domains, the DIV fluorescence signal activated much more slowly (t10-
90%C=1.91±0.44 ms at +30 mV, (7), p<0.001). Deactivation kinetics were significantly slower 
than those of the DI and DII, but 2-3 times faster than that of DIII.  Surprisingly, DIV-VSD 
deactivation did not slow with increasing pulse duration (t10-90%C=5.71±4.04 ms after a 2 ms 
pulse and 6.63±3.91 ms after 200 ms, (4), p=0.411). Given the prominent role of DIV in 
inactivation, the lack of slowing in DIV-VSD recovery with longer pulses is highly unexpected 
and is in clear contrast with NaV1.4 results8, suggesting different interactions between the DIII- 
and DIV-VSDs and inactivation.
 Our next aim was to assess the molecular pathology of two proximal DII-VSD BrS
mutations, A735V and G752R (Fig. 6).  We introduced each into the DII-LFS construct. The F-
V and SSI F-V curves of A735V were dramatically positive-shifted relative to DII-LFS (by
+49.1 mV and +58.5 mV, respectively) and also relative to the G-V and SSI curves of the 
channel itself (by +19.5 mV and +89.1 mV, respectively). In addition, the voltage-sensitivity of 
the DII-VSD was severely reduced; both had very shallow slope factors (35.4 mV and -39.5 mV, 
respectively). DII-VSD activation kinetics were also slightly slowed by the mutation at +40 mV 
based on the t10-90%C values (DII-LFS: 0.99±0.19 ms (8), DII-LFS-A735V: 1.49±0.36 ms, (5), 
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p=0.005), but even more strikingly, the DII-VSD activation rate of the mutant lost its voltage-
dependence (1.45±0.42 ms at -20 mV and 1.49±0.36 ms at +40 mV (5), p=0.850) as opposed to 
DII-LFS (1.42±0.19 ms at -20 mV and 0.99±0.19 ms at +40 mV (8), p=0.002). To the contrary, 
ionic current activation of the mutant conserved its voltage-dependence, but was slower than
DII-LFS at potentials <10 mV (t10-90%=1.48±0.17 ms (5) vs 0.71±0.47 ms (3), respectively, at -20 
mV, p=0.002).  Despite the severely right-shifted F-V of A735V, the mutant Q-V (V1/2 = -75.6 r
8.3 mV (5)) was not significantly different from that of DII-LFS (-80.0 ± 7.6 mV (4), p=0.241) 
or WT-LFS (-69.1 ± 4.2 mV (7), p=0.058). 
 In contrast, G752R caused minor F-V and SSI F-V shifts (by +1.0 mV and -9.8 mV, 
respectively, compared to DII-LFS) and displayed similar slope factors, but resulted in a severe
slowing of the DII-VSD activation. In response to a depolarizing step, the rate of DII-VSD 
activation was about 7-fold slower in the mutant than in the DII-LFS channel (t10-90%C=0.99±0.19 
ms (8) and 6.96±1.21ms (8) at +40 mV, respectively, p<0.001). The Q-V curve was right-shifted 
by ~20 mV with respect to DII-LFS. However, extending the interval over which charge was 
integrated from 10 to 20 ms, to account for G752R-induced slowing, shifted the curve leftward 
and closer to DII-LFS.  Significant slowing of activation kinetics was also observed in the ionic 
current of G752R. In the -40 to +30 mV voltage range, the activation rate was 1.7 to 2.9 times 
slower than that of the DII-LFS as measured by the t10-90% times (1.51±0.15 ms (7) and 
0.71±0.47 ms (3), respectively, at -20 mV, p<0.001; Fig S4).   
 To ensure that the mechanisms we observed in oocytes are still operative across cell 
lines, we expressed both mutants in HEK293T cells. A comparison (Fig. S5) shows that as in
oocytes, current activation measured by the t10-90% was slowed in both BrS mutants compared to 
DII-LFS (at -20 mV, DII-LFS: 0.27r0.09 ms (4), A735V: 0.81r0.32 ms (5), G752R: 0.66r0.07
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ms (4); p=0.002). 
Discussion
Our results represent the first measurements of human NaV1.5 VSD conformations and show that 
each VSD has unique kinetics, consistent with specific gating roles.  Specifically, the four VSDs 
activate at very different membrane potentials that span a range >50 mV. DIII activates at the 
most hyperpolarized potentials (V1/2=-106.0 mV), followed by DI(-83.9 mV), DIV(-66.8), and 
finally DII(-51.4), all negative of the G-V curve that characterizes current activation (V1/2=-39.9 
mV for WT-LFS). Further, all four VSDs have a t10-90 rise time that is slower than ionic current 
activation, which is to be expected if ionic current activation is due to the combined motions of 
several VSDs that can be modeled as a cubed gate (e.g., m3 in Hodgkin-Huxley type models),
allowing for a more rapid activation after a delay. 
 While our results support the hypothesis of concerted action of several VSDs in 
activating NaV channels, our mutation results contrast with classical models that require tight 
coupling of the “gates” to pore opening.  Comparing DII-VSD activation voltage-dependence in 
A735V to its G-V relationship (Fig. 6A) reveals that the channel fully opens at 0 mV, even 
though the DII-VSD is not fully activated even at +80 mV.  This phenomenon is observed in 
DII-LFS as well, indicating that this property is intrinsic to NaV1.5, but the effect is greatly 
enhanced in A735V. Thus, DII-VSD activation facilitates channel opening through an allosteric 
mechanism where lack of VSD-activation simply slows activation, but does not prevent it.  This 
mechanism may be evolutionarily beneficial, because it allows for moderate alteration of VSD 
kinetics by mutations without preventing Na+ channel activation and myocyte excitability.  
 Correlation of VSD-activation with inactivation can be assessed by comparing the SSI 
and SSI-FV curves and pulse duration protocols. The SSI protocols show that the DII-VSD is 
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least likely to participate in inactivation:  At potentials when the channel is completely blocked 
by inactivation, the DII-VSD has yet to significantly activate (Fig. 3). In contrast, the close 
overlap of the SSI and DIV SSI F-V curves supports the notion that the closed-state inactivation
reported by this protocol is tightly coupled to DIV-VSD movement.  Finally, the pulse duration 
protocol may reveal VSD interaction with deeper inactivation states that occur at depolarized 
potentials, which are likely to modulate the late Na+ current. 
7KHRULJLQRIǻ)
Our detected changes in TAMRA fluorescence emission are likely due to photo-induced electron
transfer, which is a quenching non-radiative electron transfer between two molecules that are 
within 10 Å, in close van der Waals contact23. Many different residues may quench the 
fluorophore, which implies that our fluorescence signal is highly dependent on the surrounding 
residues that interact with the fluorophore as it moves.  This dependence introduces the 
possibility that the fluorescence changes we observe do not necessarily reflect the movement of 
the charged S4 segments across the membrane.  
Our Q-V curves that are calculated from gating currents directly quantify charge transfer
within all four domains across the membrane field.  Thus, we expect that if we are tracking 
charge transfer, then the valence-weighted average midpoint of the F-V curves will match the Q-
V curves (Figure 7, Table 1)6.24  The WT-LFS Q-V is accurately reconstructed by the valence-
weighted F-V curves (Figure 7A).  Moreover the confounding left-shift in the A735V Q-V 
relative to G752R is also predicted by this analysis (Figure 7B), and results from much less 
charge being assigned to the DII F-V due to its reduced slope, which lessens its right-shifting 
contribution.   With the G752R construct, we observe less charge transferred at some of the 
lower potentials. This slight difference is likely due to the substantial slowing of charge 
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movement at these potentials, which sharply reduces the gating current and precludes its 
detection.   Alternatively, G752R may be slowing activation of the other three domains, causing 
a right-shifted Q-V.  Previous work in NaV1.4 shows that a DII-VSD activation shift modestly 
affects the activation of the DI, DIII, and DIV VSDs25.  Future efforts to probe NaV1.5
cooperativity will be needed to test whether this the case for A735V and G752R. 
A simple two-state model of the VSD would predict that the SSI-FV is simply a mirror 
image of the F-V and that they should cross at 0.5.  This is the case for the DI and DII VSDs, but 
not for the DIII- and DIV-VSDs, which showed a lower crossing.  Since the SSI-FV uses a 200 
ms pulse, whereas the F-V is measured after several ms, the difference is likely due to multiple 
activated or resting states of the VSD.  This is not surprising, as multiple DIII-VSD resting states 
have been posited to model lidocaine interaction and we also infer multiple states from the pulse 
duration protocol.  For the DIV-VSD this crossing was in the range of experimental variability, 
but may be linked to DIV-VSD interaction with inactivation.
Comparison to Previous Results 
VCF has been used to study NaV1.4, and many of the results have been extrapolated across the 
super-family of NaV channels.  While we observe many similarities, there are several distinct 
NaV1.5 features. In rNaV1.4, the VSD activation midpoints all fell within a 20 mV range. In 
contrast, midpoints of the F-V curves for hNaV1.5 spanned a range of about 50 mV. In particular, 
DIII was activated at very hyperpolarized potentials, and DII activation was substantially 
depolarized relative to the Q-V (by 30 mV).  For the DII-VSD, this depolarizing shift may be 
due to loose coupling between the DII-VSD and channel activation, which was not observed in 
NaV1.4. 
Further differences are seen when comparing the connection between inactivation and  
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VSD activation.  Classical studies of NaV channel gating charge movement found that, following 
prolonged depolarization, a fraction of the gating charge is “immobilized”: that is, it returns with 
much slower kinetics upon repolarization than the majority of the charge26. In human NaV1.4,
this immobilized fraction was associated with DIII and DIV8.  Consistently, hNaV1.5 DI- and 
DII-VSD deactivation was independent of the length of the depolarizing pulse. Conversely,
return of the hNaV1.5 DIII-VSD was significantly slowed by long depolarizations, while the 
DIV-VSD deactivation rate was unaffected, in clear contrast to NaV1.4. However, this 
observation is in agreement with previous reports showing that charge immobilization of the 
NaV1.5 DIV-VSD is independent of inactivation, and that the inactivation particle can only 
modulate gating charge recovery of DIII, but not DIV27.  Thus our data reconciles these two 
previously discrepant results by showing that the hNaV1.5 VSDs interact with inactivation
uniquely. 
Many have previously probed the functional contributions of each VSD to NaV1.5 gating, 
and our data shows the timing of these contributions.  For example, outward stabilization of the 
DI-S4 strongly reduced peak NaV1.5 current (45%) without affecting rapid channel kinetics28.  In 
our data, we observed a slow DI-VSD transition at elevated potentials that may be linked to this 
peak reduction through slow inactivation (Figure 2).  In contrast, DII-VSD outward stabilization 
does affect rapid gating kinetics, shifting the G-V leftward along with SSI28.  Our results show 
that this DII-VSD regulation of channel activation is through an allosteric connection, which 
facilitates channel opening when the DII-VSD is activated.  Similar work has also probed the 
consequences of DIII and DIV-VSD outward stabilization29, both of which alter channel 
availability without affecting activation.  While the link between the four VSDs and inactivation 
is consistent with our results, it remains to be seen whether a slowing of DI, DIII or DIV may
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also affect channel activation as observed in DII.
Relevance
For the inherited BrS1 mutations, A735V and G752R, we observed two very different molecular 
pathologies (Fig 6).   A735V clearly shifts the voltage dependence, while at positive potentials 
DII-VSD activation kinetics are nearly as rapid as WT.  In contrast, DII-VSD voltage-
dependence is preserved with G752R, but it arrives at its steady state much more slowly. For 
both mutants, the consequence for the ionic current is slower activation.  Thus, our results show 
that dramatically different molecular pathologies can give rise to very similar ionic current 
phenotypes.  Still, molecular-level differences are likely to have significant consequences for the 
interaction of the channel with anti-arrhythmic therapies.
From a theoretical perspective, the non-canonical NaV1.5 activation mechanism revealed 
by the G752R and A735V mutations suggests a very specific Markov state diagram where 
opening is possible from closed states where the VSDs are not yet activated.  Recent work on L-
type Ca2+ channels revealed that this type of allosteric model was best suited to describe its data.  
Given the recent attention to similarities between Ca2+ and Na+ channels it would not be 
surprising if a similar model would be more suitable for describing NaV1.5 gating.  We expect 
that future work probing the contribution of each VSD to channel gating will be immensely 
useful for informing these widely used models. 
Future Directions
As demonstrated by our ability to observe the molecular pathology of two BrS1 mutations, we 
expect that we will be able to better understand mechanisms whereby some of the >150 NaV1.5
inherited mutations cause disease.  In addition, NaV1.5 is known to interact with many accessory 
proteins, and it is tightly controlled by post-translational modification.  By observing how these 
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modulatory proteins and modifications affect the VSDs, we expect to unravel molecular 
mechanisms whereby the cell regulates hNaV1.5 gating to modulate cardiac myocyte excitability.   
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Table 1: Parameters of Boltzmann-fits to G-V, F-V, SSI, SSI-FV and Q-V curves
WT WT-LFS DI-LFS DII-LFS DIII-LFS DIV-LFS A735V G752R 
G-V V1/2 -39.6±2.5 -39.9±7.1 -56.7±5.0 -38.9±3.0 -40.0±4.4 -34.6±3.4 -21.8±6.2 -25.9±3.7 
k
n
9.7±1.0 
(20) 
8.8±1.2 
(7)
8.2±1.5 
(13) 
8.5±1.2 
(9)
9.4±0.7 
(13) 
9.2±0.6 
(19) 
8.6±1.1 
(5)
8.7±0.7 
(7)
SSI V1/2 -80.6±6.0 -86.6±5.7 -78.6±2.1 -79.2±4.5 -76.2±2.5 -74.2±3.1 -83.1±6.5 -83.2±3.9 
k
n
-8.4±0.8 
(22) 
-6.8±0.5 
(6)
-6.4±0.2 
(8)
-6.5±0.9 
(7) 
-6.7±0.4 
(17) 
-10.3±0.9 
(13) 
-6.6±0.4 
(3)
-6.8±0.8 
(6)
F-V V1/2 -83.9±6.9 -51.4±6.7 -106.0±7.6 -66.8±8.3 -2.3±7.8 -50.4±3.3 
k
n
16.8±2.9 
(7)
20.5±2.3 
(8)
21.7±2.1 
(8)
14.6±2.9 
(12) 
35.4±1.7 
(5)
18.7±2.6 
(8)
SSI F-V V1/2 -81.4±5.3 -52.2±6.7 -119.4±7.2 -75.0±8.0 6.0±5.2 -62.0±5.6 
k
n
-15.4±1.9 
(5)
-17.5±1.7 
(6) 
-17.7±1.7 
(5) 
-10.9±4.5 
(4)
-39.5±5.6 
(3)
-21.5±3.2 
(7)
QON V1/2 -69.1±4.2 -77.8±16.5 -80.0±7.6 -71.6±2.9 -66.6±8.7 -75.6r8.3 -58.5r4.9
k
n
21.4±2.0 
(7)
24.8±2.9 
(4)
21.6±3.5 
(4)
25.6±1.0 
(5) 
27.1±2.7 
(5) 
23.6r1.9
(5)
19.6r3.6
(6)
QOFF V1/2 -75.8±3.9 -74.9±7.3 -75.8±4.1 -71.2±10.9 -66.8±8.6 -79.7r3.3 -65.0r5.1
k
n
22.1±2.7 
(7)
25.5±6.0 
(4)
22.6±4.5 
(4)
28.6±4.2 
(5) 
23.9±5.6 
(5) 
25.3r4.2
(5)
25.2r3.1
(6)
Errors represent 95% confidence intervals, numbers in parentheses indicate the number of cells measured 
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Figure Legends:
Figure 1: WT-LFS ionic and gating currents. Currents from WT-LFS and WT channels were 
recorded in the cut-open oocyte configuration.  The mean±95CI for groups of 6 to 22 cells are 
reported. (A) Top: Ionic currents.  From -100 mV, a 50 ms step to -120 preceded 100 ms 
depolarizing pulses from -140 to +40 mV in 10 mV steps, which were followed by a 50 ms step 
to -120 mV before returning to holding potential.  Membrane capacitance and leak were removed 
using P/-8 leak subtraction. For clarity, only the first 40 ms of traces corresponding to -130 to 
+30 mV in 20 mV steps are shown.  Bottom: Voltage-dependence of steady-state activation and 
steady-state inactivation curves for the WT-LFS (G-V: black circles, SSI: black squares) and the 
WT channels (G-V, gray up triangle; SSI, gray down triangle). G-V curves were constructed 
from I-V relationships recorded from cells depolarized in 10 or 20 mV increments from -120 
mV. Na+ reversal potential was determined for each cell individually. For the SSI curve, cells
were held at potentials ranging from -150 to +20 mV for 200 ms, and the available fraction was 
assessed by a -20 mV test pulse. See Table 1 for Boltzmann-fit parameters. (B) Top: Gating 
currents from WT-LFS channels were recorded during 20-ms depolarizing steps ranging from -
150 to +50 mV in 20-mV steps. Capacitance and leak were removed using P/4 leak subtraction 
with a sub-sweep holding level of +40 mV. Bottom: Gating currents were integrated for 10 ms 
following the voltage change. 
Figure 2: V215C (DI-LFS) ionic currents and fluorescence. Na+ currents and fluorescence were 
recorded from human NaV1.5 channels carrying the LFS-S215C mutations with cut-open oocyte 
voltage-clamp fluorometry, see Materials and Methods.   The mean±95CI for groups of 4 to 14 
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cells is reported. A) Top: Ionic currents (above) and fluorescence signals (below).  From -100 
mV, a 50 ms step to -120 preceded 20 ms-long depolarizing pulses ranging from -150 to +30 mV 
in 20 mV steps. These steps were then followed by a 50 ms step to -120 mV before returning to 
the holding potential.  Membrane capacitance and leak were removed using P/-8 leak 
subtraction. For clarity, only traces corresponding to -150, -90, -30, and +30 mV are shown. 
Bottom: G-V curve (black circles) and SSI (black squares) and the corresponding fluorescence 
signals (orange circles and squares, respectively). All curves were obtained by Fig. 1 protocols. 
The fluorescence amplitude for the FV and SSI-FV curves was determined by taking the mean of 
the signal for at least 3 ms at the greatest displacement of the signal.  For the SSI-FV curve, 'F
was calculated as the difference between the signal amplitude measured at the conditioning 
potential and -20 mV. Boltzmann-fit parameters in Table 1. Dotted lines represent WT-LFS G-V
and SSI curves for comparison. B) Top: Tail currents and fluorescence measured at -120 mV 
following depolarizing steps to +50 mV for 2 (black) or 200 ms (orange). Inactivation does not 
occur during the shorter pulse resulting in a large tail current.  Bottom: t10-90%,C values calculated 
from deactivation time constants of the fluorescence signal from exponential fits following the 
step back to -120 mV, from depolarizing steps to 0 or +50 mV for 1 to 200 ms durations.  
Figure 3: DII-LFS (S805C) ionic currents and fluorescence. Na+ currents and fluorescence were 
recorded from DII-LFS. Conditions were as in Figure 2 unless noted. Mean±95CI is reported for 
groups of 3 to 9 cells. A) Top: Ionic currents (above) and fluorescence (below). Bottom: G-V
curve (black circles), SSI (black squares), and the corresponding fluorescence (green circles and 
squares, respectively). Curves were constructed as in Figure 2. Boltzmann-fit parameters in 
Table 1. Dotted lines represent WT G-V and SSI curves for comparison. B) Tail currents and 
DOI: 10.1161/CIRCEP.115.003155
23
fluorescence measured following the step back to -120 mV from depolarizing steps to +50 mV 
for 2 (black) or 200 ms (green). t10-90%,C values calculated from deactivation time constants of the 
fluorescence signal from exponential fits following the step back to -120 mV, from depolarizing 
steps to 0 or +50 mV for 1 to 200 ms durations.  
Figure 4: DIII-LFS (M1296C) ionic currents and fluorescence. Na+ currents and fluorescence 
from DIII-LFS. Mean±95CI is reported for groups of 5 to 17 cells. A) Top: Ionic currents 
(above) and fluorescence (below) were recorded during 20 ms pulses ranging from -170 to +30 
mV in 20 mV steps. For clarity, only traces corresponding to -170, -110, -50, and +10 mV are 
shown. Bottom: G-V (black circles), SSI (black squares), and the corresponding fluorescence 
signals (blue circles and squares, respectively). Curves were constructed as in Figure 2. 
Boltzmann-fit parameters in Table 1. For comparison, dotted lines represent WT G-V and SSI 
curves. B) Tail currents and fluorescence measured following the step back to -120 mV from 
depolarizing steps to +50 mV for 2 (black) or 200 ms (green) pulses. Red dotted lines indicate 
exponential fits to the fluorescence traces. Time constants for this cell were 4.1 and 7.5 ms after 
2 and 200 ms-long depolarizations, respectively.  t10-90%,C values calculated from deactivation 
time constants of the fluorescence signal from exponential fits following the step back to -120 
mV, from depolarizing steps to 0 or +50 mV for 1 to 200 ms durations. 
Figure 5: DIV-LFS (S1618C) ionic currents and fluorescence. Na+ currents and fluorescence 
from DIV-LFS. Mean±95CI is reported for groups of 3 to 20 cells. A) Top: Ionic currents 
(above) and fluorescence (below) as in Figure 2.  Only traces from -150, -90, -30, and +30 mV 
are shown for clarity. G-V (black circles) and SSI (black squares), and the corresponding 
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fluorescence signals (purple circles and squares, respectively). Curves were constructed as in 
Figure 2. Boltzmann-fit parameters in Table 1. Dotted lines represent WT G-V and SSI curves 
for comparison. B) Top: Tail currents and fluorescence measured during step back to -120 mV 
from steps to +50 mV for 2 (black) or 200 ms (green) pulses.  Bottom: t10-90%,C values calculated 
from deactivation time constants of the fluorescence signal from exponential fits following the 
step back to -120 mV, from depolarizing steps to 0 or +50 mV for 1 to 200 ms durations.  
Figure 6: DII-LFS-A735V and DII-LFS-G752R Brugada syndrome mutants. Na+ currents and 
fluorescence were recorded from A735V (left panels) and G752R (right panels) mutations in the 
DII-LFS background. Mean±95CI is reported for groups of 3 to 8 cells. Ionic currents (top) and 
fluorescence (below) from DII-LFS-A735V (A) and DII-LFS-G752R (B) channels were 
recorded during 50 ms-long pulses ranging from -140 to +60 mV in 20 mV steps. For clarity, 
only -140, -80, -20 and +40 mV traces are shown. Kinetics of VSD activation in DII-LFS-
A735V and DII-LFS-G752R channels are tracked by the fluorescence signal. For comparison the 
gray dotted line represents a normalized signal from DII-LFS recorded at +40 mV. G-V (black 
circles) and SSI (black squares), and the corresponding fluorescence signals (green circles and 
squares, respectively) for DII-LFS-A735V and DII-LFS-G752R channels. For comparison, 
dotted lines represent DII-LFS curves. Voltage-dependence of integrated gating charge 
movement over 10 ms for A735V and G752R channels. Dashed black line indicates the Q-V
function of the ON gating current of WT-LFS for reference.  For G752R, dashed green line 
shows gating charge calculated from a 20 ms interval.
Figure 7: Comparison of valence-weighted F-V functions to Q-V functions. F-V curves from
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each domain and the valence-weighted sum of these functions24 (grey) are shown along with the 
Q-V curves (black) for (A) WT-LFS, (B) A735V and (C) G752R.  For G752R, the 20 ms 
integral is shown (Fig 6B), and the F-V was also measured at 20 ms.







